NEW YORK (GenomeWeb) – NanoString Technologies said today that Anthem has issued a positive coverage decision for its US Food and Drug Administration-cleared Prosigna breast cancer assay.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.